|
|
Analysis of grey area of Treponema pallidum specific antibody detection |
ZHAO Jing BIAN Chengrong LI Boan WANG Han |
Clinical Laboratory Medical Center, the Fifth Medical Center, General Hospital of PLA, Military Clinical Laboratory Diagnostic Center for Infectious Diseases, Beijing 100039, China |
|
|
Abstract Objective To investigate the grey area of Treponema pallidum specific antibody detected by chemiluminescent immunoassay, and improve the validity and accuracy of syphilis laboratory diagnosis. Methods The patients with cut-off (S/CO) value 1 to 9 (assumed grey area) of Treponema pallidum specific antibody detected by chemiluminescent immunoassay from February 2016 to May 2018 were collected from the Fifth Medical Center in General Hospital of PLA. The false positive rate of chemiluminescent immunoassay in grey area was evaluated by using the methods of reverse detection process of syphilis laboratory and the results of immunoblotting as gold standard. Results A total of 25 190 cases were detected by chemiluminescent immunoassay, and 462 cases (1.83%) were observed within grey area. The false positive rate was 0.74% in 234 cases with S/CO values ranging from 1 to 3, 0.27% in 109 patients with S/CO values ranging from greater than 3 to 6, and 0.12% in 119 patients with S/CO values ranging from greater than 6 to 9. There was a significant difference among three groups (P < 0.05). Comparison of S/CO values in greater than 6 to 9 patients with lower false positive rate, the false positive rate of S/CO value greater than 6 to 7 was 0.072%, the false positive rate of S/CO value greater than 7 to 8 was 0.024%, the false positive rate of S/CO value greater than 8 to 9 was 0.020%, and the difference between three groups was statistically significant (P < 0.05). Conclusion In the assumed grey area, when the specific antibody of Treponema pallidum is detected by chemiluminescent immunoassay, the false positive rate showes a decreasing trend with the increase of S/CO value. The gray area should be set to S/CO value of 1 to 7.
|
|
|
|
|
[1] Sommese L,Paolillo R,Sabia C,et al. Syphilis detection:evaluation of serological screening and pilot reverse confirmatory assay algorithm in blood donors [J]. Int J Std Aids,2016,27(8):644-649.
[2] Cruz AR,Ramirez LG,Zuluaga AV,et al. Immune evasion and recognition of the syphilis spirochete in blood and skin of secondary syphilis patients:two immunologically distinct compartments [J]. PLoS Negl Trop Dis,2012,6(7):e1717.
[3] Jantzen SU,Ferrea S,Langebner T,et al. Late-stage neurosyphilis presenting with severe neuropsychiatric deficits:diagnosis,therapy,and course of three patients [J]. J Neurol,2012,259(4):720-728.
[4] Sommese L,Sabia C,Esposito A,et al. Comparison of performance of two Treponema pallidum automated chemiluminescent immunoassays in blood donors [J]. Infect Dis(Lond),2016,48(6):483-487.
[5] 王林.酶联免疫吸附试验“灰区”不合格在无偿献血血液检测中的作用与意义[J].检验医学与临床,2014,11(2):237-238.
[6] 李媛,谭艳.ELISA检测血清HBsAg、抗-HCV、抗-TP、抗-HIV灰区设定的探讨[J].国际检验医学杂志,2017, 38(6):810-812.
[7] 国家卫生健康委员会.中华人民共和国卫生行业标准-梅毒诊断(WS 273—2018)[S]. 2018-03-06.
[8] 房华,吴燕芬,汪瑞忠,等.全自动化学发光免疫分析仪在梅毒螺旋体抗体检测中的临床应用[J].中国皮肤性病学杂志,2010,24(7):671-672.
[9] Zhiyan L,Meiling W,Ping L,et al. Consistency between Treponema pallidum particle agglutination assay and architect chemiluminescent microparticle immunoassay and characterization of inconsistent samples [J]. J Clin Lab Anal,2015,29(4):281-284.
[10] 董旭才,刘昕阳,张婧,等.酶联免疫吸附法检测梅毒抗体试验灰区结果分析[J].国际检验医学杂志,2014,35(5):598.
[11] 赵娟,谭延国.化学发光法检测梅毒抗体的实验评价[J].中国皮肤性病学杂志,2008,22(10):626-627.
[12] Wang KD,Xu DJ,Su JR. Preferable procedure for the screening of syphilis in clinical laboratories in China [J]. Infect Dis(Lond),2016,48(1):26-31.
[13] 陈兰兰,邵燕玲,王巧凤,等.自动化梅毒螺旋体抗体初筛实验的研究[J].中华检验医学杂志,2013,36(10):891-894.
[14] Zhu WF,Lei SY,Li LJ. Hepatitis C virus infection and biological false positive syphilis test:a single-center experience [J]. Hepatobiliary Pancreat Dis Int,2011,10(4):399-402.
[15] Ong JJ,Fu H,Smith MK,et al. Expanding syphilis testing:a scoping review of syphilis testing interventions among key populations [J]. Expert Rev Anti Infect Ther,2018,16(5):423-432.
[16] Li Z,Feng Z,Liu P,et al. Screening for antibodies against Treponema pallidum with chemiluminescent microparticle immunoassay:analysis of discordant serology results and clinical characterization [J]. Ann Clin Biochem,2016,53(Pt 5):588-592.
[17] Ortiz DA,Loeffelholz MJ. Evaluation of the lumipulse G TP-N chemiluminescent immunoassay as a syphilis screening test [J]. J Clin Microbiol,2017,55(11):3236-3241.
[18] 曹雁,杨围,毛跃,等.43例梅毒假阳性结果分析[J].西南军医,2006,8(5):48-49.
[19] Alan F,Heather L. HCV Antibody Tests [J]. Hcvadvocate Org,2013,11(5):1-4.
[20] 赵静,马洪滨,陈霖,等.酶联免疫加速仪与水浴孵育方法对梅毒螺旋体抗体检测的比较[J].医疗卫生装备,2013,34(11):61-62. |
|
|
|